Law ❯ Litigation ❯ Class Action Lawsuits ❯ Legal Representation

Contingency Fees

Veritone Admits Q3 2025 Revenue Accounting Errors and Draws Multiple Investor Lawsuits

The company says it misapplied ASC 606 rules, triggering restatement work and competing securities claims that could lead to regulatory review.

Investors File Securities Suit Over Graphic Packaging Inventory Problems

AeroVironment Faces Securities Claims Over BlueHalo BADGER Work

Lawsuits Follow Verra Mobility’s Loss of Avis Contract as Firms Vie to Lead Investor Class

Securities Class Action Filed Over Via Transportation’s 2025 IPO

Law Firms Seek Lead Plaintiffs in Securities Suit Over Zoetis Pet-Drug Claims

Multiple Plaintiff Firms Press Investors to Lead FS KKR Capital Securities Lawsuit

Multiple Firms Compete to Lead Medpace Securities Suit After Lower Book‑to‑Bill Disclosure

Multiple Firms Seek Lead Role in Securities Suit Over Commvault’s ARR Shortfall

Investors File Securities Suit Against Regencell as Firms Seek Lead Plaintiff

Gossamer Bio Faces Class Actions After Phase 3 PROSERA Misses Primary Endpoint

FS KKR Capital Sued in Securities Class Action as Firms Seek Lead Plaintiff

Atara Faces Investor Class Action Over FDA Rejections of EBVALLO

Pinterest Faces Securities Class Action as Investors Are Urged to Seek Lead Role by May 29

Gossamer Bio Faces Securities Class Action After PROSERA Failure, 80% Stock Plunge

Pomerantz Files Securities Class Action Against Nektar Over REZOLVE‑AA Trial Disclosures

Medpace Hit With Securities Class Action Over Book-to-Bill and Cancellation Claims

ImmunityBio Investors Urged to Seek Lead Role in Suit After FDA Rebuke Over Anktiva Ads

Investor Lawyers Press April Deadlines in Lakeland and Navan Securities Cases

Plaintiff Firms Push Investor Alerts on Securities Suits as Filing Deadlines Near